BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 5, 2020
View Archived Issues
Another reason to get a flu shot
Read More
Cerebrospinal fluid is early culprit in stroke edema
Read More
A pan-RAS antibody effectively inhibits in vitro and in vivo growth of RAS mutant-dependent tumors
Read More
Single-cell analysis of uveal melanoma TME identifies LAG3 as a candidate for checkpoint blockade
Read More
Gene transfer-mediated expression of anti-pTau Ab in the CNS for chronic traumatic encephalopathy
Read More
Agmatine is decreased in sepsis and may be a clinical biomarker and therapeutic agent
Read More
Saroglitazar approved in India as add on treatment for type 2 diabetes
Read More
First patient dosed in phase II study of AKST-4290 in in Parkinson's disease
Read More
AskBio doses first patient in phase I study of NAN-101
Read More
Novel motheaten spontaneous mutation mouse model of otitis media
Read More
Phase I/II data presented for Pexa-Vec plus durvalumab in CRC
Read More
Phase II study of SHR-1210 plus gemcitabine and oxaliplatin meets primary endpoint in BTC
Read More
Alkermes Pharma presents new naltrexone prodrugs for drug dependency
Read More
Heparegenix identifies MAP2K4 inhibitors
Read More
Medshine Discovery synthesizes new FGFR and HGFR inhibitors
Read More
Esteve Pharmaceuticals presents new analgesics
Read More
Chiesi Farmaceutici divulges new ROCK inhibitors
Read More
Researchers cast wide net for rapid-draw weapons in 2019-nCoV fight
Read More
Regeneron expands agreement with HHS to develop treatments for 2019-nCoV
Read More
Phase II data presented for lenvatinib plus pembrolizumab in patients with advanced gastric cancer
Read More
Hoth Therapeutics begins preclinical gene therapy study for asthma and allergic inflammation
Read More
Long-lasting responses seen with regorafenib plus nivolumab in REGONIVO study
Read More
FDA issues EUA for CDC's 2019-nCoV Real-Time RT-PCR Diagnostic Panel
Read More